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MIDDLES
Towards a more rapid diagnosis of rapidly progressive
glomerulonephritis
Michael J D Cassidy, Gillian Gaskin, John Savill, Charles D Pusey, Andrew J Rees
Abstract
An attempt was made to provide simple practical
guidelines to alert general practitioners to the diag-
nosis of rapidly progressive glomerulonephritis and
lead to early referral to hospital. The duration of
illness before referral to this hospital and its effect on
outcome in patients with crescentic nephritis were
assessed retrospectively from the case notes of 24
patients referred over two years. Four patients had
Goodpasture's syndrome, 11 Wegener's granulo-
matosis, seven microscopic polyarteritis, and
two idiopathic progressive glomerulonephritis. The
duration of symptoms before referral to the local
hospital was similar in the four groups of patients
and varied from one week to 28 months (mean 10
months). The duration of stay in the local hospital
was two, nine, 11, and 180 days in the patients with
Goodpasture's syndrome and a mean of four days
(range one to eight) in those with Wegener's granulo-
matosis and 10 days (one to 18 days) in those with
microscopic polyarteritis. In the local hospital the
diagnosis was based on the results of renal biopsy
and detection of antibodies to glomerular basement
membrane in two patients with Goodpasture's
syndrome and on the results of renal biopsy in seven
of the other patients aided by the detection of
antibodies to the cytoplasm of neutrophils (ANCA)
in 10. Three of the 24 patients died and four required
maintenance haemodialysis.
Patients who present to their general practitioners
with persistent non-specific symptoms should have
a urine dipstick test and then blood tests and
emergency referral to hospital if necessary. Hospital
physicians should be aware of the speed and accu-
racy with which current assays can confirm a diag-
nosis of rapidly progressive glomerulonephritis.
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Introduction
Rapidly progressive glomerulonephritis, the clinical
counterpart of focal necrotising glomerulonephritis
with epithelial crescents, is an aggressive condition
that can occur in a wide variety of clinical diseases but
is most often associated with either systemic vasculitis
or circulating antibodies to glomerular basement
membrane (Goodpasture's syndrome).' Recently anti-
bodies to the cytoplasm of neutrophils (ANCA) have
been detected in the serum of a high proportion of
patients with systemic vasculitis. There are at least
two types: antibodies to components of cytoplasm
(c-ANCA), which occur in classical Wegener's granu-
lomatosis, and antibodies to components of the peri-
nuclear region of cytoplasm (p-ANCA), which are
found in patients with microscopic polyarteritis and
idiopathic rapidly progressive glomerulonephritis.2
Serological tests are extremely useful when making a
diagnosis, but ultimately this must be based on the
results of renal biopsy.
If untreated rapidly progressive glomerulonephritis
results in dialysis or death in over 90% of patients.
Specific treatment with corticosteroids, cytotoxic
agents, and, in severe cases, plasma exchange has
considerably improved the outlook. Even so, recovery
of renal function in patients who have progressed to
needing dialysis rarely occurs in those with Good-
pasture's syndrome despite aggressive treatment; this
is not true in those with Wegener's granulomatosis
or microscopic polyarteritis, in whom aggressive treat-
ment is often rewarding.3
We retrospectively analysed data from the case notes
of such patients with crescentic nephritis referred to
our unit over two years to assess the duration of illness
before referral and the effect on outcome. We aimed to
provide simple practical guidelines to alert general
practitioners to the potential diagnosis and lead to early
hospital referral.
Patients and methods
From January 1988 to December 1989, 24 patients
(nine men, 15 women) with rapidly progressive glo-
merulonephritis were referred to this hospital from
other hospitals. The mean age of the group was 56
(range 22 to 76). Four patients had Goodpasture's
syndrome (positive results of tests for antibodies to
glomerular basement membrane and linear deposition
of IgG on the glomerular basement membrane in a
renal biopsy specimen); 11 had Wegener's granulo-
matosis; seven had microscopic polyarteritis as
previously described4'; and two were classified as
having idiopathic rapidly progressive glomerulo-
nephritis. All 20 patients who did not have Good-
pasture's syndrome had antibodies to the cytoplasm of
neutrophils detected by indirect immunofluorescence.
The duration ofsymptoms consistent with their under-
lying disease before referral to their local hospital was
recorded, as was the serum creatinine concentration at
presentation. The duration of attendance or admission
at the local hospital before referral to our unit was
noted. These data were analysed with special reference
to outcome.
Results
The duration of symptoms before referral to the
local hospital varied from one week to 28 months
(mean 10 months). The mean duration was similar in
all three categories of disease: 10 months in the patients
with Goodpasture's syndrome, 11 months in those
with Wegener's granulomatosis, and eight months in
those with microscopic polyarteritis and idiopathic
rapidly progressive glomerulonephritis.
All four patients with Goodpasture's syndrome had
serum creatinine concentrations of less than 700 FtmolIl
at presentation to their local hospital, but by the time of
referral to our unit all required dialysis. Their duration
of stay at the local hospital was two, nine, 11, and 180
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days. In two patients the diagnosis was made on the
basis of a positive result of an assay for antibodies to
glomerular basement membrane and findings on renal
biopsy before transfer. Despite plasma exchange and
immunosuppressive treatment3 one patient died and
two required maintenance dialysis. One patient
recovered renal function.
The average duration of stay in hospital before
referral was four days (range one to eight days) for the
patients with Wegener's granulomatosis and 10 days
(range one to 18 days) for those with microscopic
polyarteritis. The diagnosis was based on the results of
renal biopsy at the referring hospital in seven of the
20 patients, and immunosuppressive treatment was
started in 12. The diagnosis was made or supported by
detection of antibodies to the cytoplasm of neutrophils
in 10 of the 20 serum samples analysed before transfer.
Three patients were already receiving dialysis at the
time of transfer and dialysis became necessary in a
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FIG 1-Serum creatinine concentration in patients with Wegener's
granulomatosis, microscopic polyarteritis and idiopathic rapidly pro-
gressive glomerulonephritis, and Goodpasture's syndrome at three
stages after presentation.
D=Dialysis
further four. Two patients died and two required
maintenance dialysis. At two month follow up renal
function had improved in the remaining patients
(fig ).
Discussion
In most patients initial symptoms were non-specific,
such as malaise and joint pains; as expected, ear, nose,
and throat symptoms were common in the patients
with Wegener's granulomatosis. Initially, it would be
difficult to distinguish these symptoms from those of
a common viral infection. A multisystem disease
affecting the kidneys was not considered for some time
in many cases: symptoms persisted for more than four
weeks in over 80% of the patients.
Urine analysis is crucial to early diagnosis. Blood
and protein are invariably present in the urine and can
be readily detected by dipstick testing. Microscopical
examination of a fresh urine sample should be manda-
tory in hospital in such cases as red cells and casts
further suggest active glomerulonephritis. We realise
that for a general practitioner microscopical examina-
tion of urine, though desirable, requires additional
equipment and time and that time is in short supply; at
this stage dipstick testing is enough to alert suspicion.
Renal function can then be checked: the serum creati-
nine concentration, a more reliable marker of intrinsic
renal disease than urea concentration, is usually
reported, together with other biochemical variables
measured with an autoanalyser. Other markers of
active vasculitis are a low serum albumin concentration
and an increased alkaline phosphatase activity. Once a
clinically suspected diagnosis of rapidly progressive
glomerulonephritis is confirmed the patient should be
treated as a medical emergency. Immediate referral
to hospital is necessary, where a full clinical and
serological investigation including renal biopsy will
confirm the diagnosis.
Serological investigations such as specific solid phase
immunoassays for circulating antibodies to glomerular
basement membrane have been available for several
years and permit rapid diagnosis of Goodpasture's
syndrome. More recently, antibodies to cytoplasmic
constituents of neutrophils and monocytes have been
described. These have been reported to have sensitivi-
ties and specificities of over 90% in active Wegener's
granulomatosis and microscopic polyarteritis.2 In fact,
the presence of these antibodies was the basis for
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diagnosis before referral in half of the patients in this
study. Indirect immunofluorescence or solid phase
immunoassays to detect antibodies to the cytoplasm of
neutrophils are becoming more widely available and
have greatly helped in diagnosis.
We suggest that patients who present to their general
practitioners with persistent non-specific symptoms
should have a urine dipstick test followed by blood
tests and urgent referral to hospital if necessary; figure
2 shows an algorithm to illustrate this. Hospital doctors
should be aware of the speed and accuracy with which
current assays can confirm a diagnosis of rapidly
progressive glomerulonephritis. This approach should
reduce the morbidity and mortality associated with this
group of diseases.
I Pusey CD, Lockwood CM. Autoimmunity in rapidly progressive glomerulo-
nephritis. Kidney Int 1989;35:929-37.
2 Van der Woude FJ, Daha MR, Van Es LA. The current status of neutrophil
cytoplasmic antibodies. Clin Exp Immunol 1989;78:143-8.
3 Hind CKR, Paraskevakou H, Lockwood CM, et al. Prognosis after immuLno-
suppression of patients with crescentic glomerulonephritis requiring dialysis.
Lancet 1983;ii:263-6.
4 Pinching AJ, Lockwood CM, Pussell BA, et al. Wegener's granulomatosis:
observations on 18 patients with severe renal disease. Q J Med 1983;208:
435-60.
5 Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CMi. Microscopic
polyarteritis: presentation, pathology and prognosis. Q J Med 1985;56:
467-84.
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The classic description of Wilson's disease is a
progressive dystonic neurological disorder in young
adults who have a chronic liver disease determined
by examination, investigation, or at necropsy. A
progressive accumulation of copper in the liver and
spillover to the brain is well established. The cause of
the hepatic copper retention remains unknown,
although defective incorporation of copper into
caeruloplasmin and decreased biliary excretion of
copper have been suggested.' 2 It is well accepted that
patients with Wilson's disease often present with liver
disease alone in childhood and early adult life, and it is
generally agreed that Wilson's disease is the most
common definable cause of chronic liver disease in later
childhood.' The fallibility of the standard diagnostic
tests for Wilson's disease in this age group is also well
recognised: Kayser-Fleischer rings may be absent and
serum copper and caeruloplasmin concentrations may
be normal or near normal."-' The copper content of the
liver and profile of clearance of copper-64 from the
blood4 must be estimated in these cases.
Wilson's disease is not generally considered in
patients aged over 30 presenting with liver disease
without neurological signs, and the fallibility of
standarci tests in such patients is not well recognised.
Indeed, most reports of large series of patients with
Wilson's disease include no such case. Scheinberg
and Sternlieb mention two patients aged 30 to 35,2 and
another study briefly mentions four patients with onset
at 37, 37, 47, and 55 years of age but gives no clinical
details or results of tests.5 The man aged 55 was
probably the same one described in another report6: he
had Kayser-Fleischer rings, low serum caeruloplasmin
and copper concentrations, and an abnormal rate of
copper clearance.
We report on four adults with Wilson's disease aged
43-58 who presented within 12 months with chronic or
acute on chronic liver disease without neurological
symptoms in whom assay of hepatic copper content or
clearance of 64Cu from the blood, or both, were
required to diagnose their condition.
Case reports
Case I -A man aged 43 presented with general
malaise, loss of energy, and mild jaundice. He had
a history of pulmonary sarcoidosis, which had
been diagnosed when he was 34 and treated with
corticosteroids; vitiligo for 10 years; and steatorrhoea
due to pancreatic insufficiency, which had been
diagnosed when he was 40 and treated with pancreatic
enzyme replacement. None of the known hepatitis
viruses could be identified, autoantibody tests yielded
negative results, and his alcohol intake was minimal.
Kayser-Fleischer rings were not visible with a slit
lamp, and his serum copper concentration was normal
(24 [tmol/l). A liver biopsy showed cirrhosis with no
features of cholestasis or primary biliary cirrhosis, but
the copper content had not been measured. His rate of
clearance ofMCu was measured by injecting the isotope
intravenously and taking serum samples at 0, 5, and
30 minutes and 1, 2, 4, 24, and 48 hours. The results
were typical of Wilson's disease (figure). After six
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Clearance of intravenously injected 6Cu in patient with Wilson's
disease
months of treatment with penicillamine (500 mg twice
daily) and zinc sulphate (220 mg (50 mg zinc) three
times daily) his liver function improved. Wilson's
disease was excluded in his younger sister by testing
her clearance of 64Cu.
Case 2-A 48 year old man was diagnosed as
suffering from cirrhosis after hepatomegaly was noted
as an incidental finding. He had no relevant symptoms
or history. He had never drunk alcohol, none of
the known hepatitis viruses could be identified,
and no autoantibodies were detected. He had no
Kayser-Fleischer rings, and his serum copper and
caeruloplasmin concentrations were normal (22 Rmol/l
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